Document is current
Any future updates will be listed below
-
Authors
Zhuang, Jianjian
Li, Yue
Huang, Yi Ling
Wang, Xiang
Lin, Neng Ming
-
Funding
Funding for this research was provided by:
Zhejiang Provincial Natural Science Foundation of China (LQ23H290006)
National Natural Science Foundation of China (82204781)
Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project (2023ZR119)
Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province (2020E10021)
Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (ZWB-2020-18)
- License Information
-
More Information
Article History
Received: 2 July 2025
Accepted: 9 October 2025
First Online: 24 December 2025
Declarations
:
: The bone marrow mesenchymal stem cells used in this study were obtained from PUHE Biotechnology. The company has verified that proper ethical approval was secured for the original cell collection.
: Not applicable.
: The authors declare no competing interests.
